VOLUME 63   2002   NUMBER 5

Issue to be mailed: May 15, 2002

CME Pretest 381

CME Posttest 460

Brainstorms

382 The Psychopharmacology of Painful Physical Symptoms in Depression. Stephen M. Stahl
[PDF]

Original Articles

384 Nonadherence With Mood Stabilizers: Prevalence and Predictors. [CME] Jan Scott and Marie Pope
[Abstract] [PDF]

391 Olanzapine in the Treatment of Apathy in Previously Depressed Participants Maintained With Selective Serotonin Reuptake Inhibitors: An Open-Label, Flexible-Dose Study. Lauren B. Marangell, Christopher R. Johnson, Barbara Kertz, Holly A. Zboyan, and James M. Martinez
[Abstract] [PDF]

396 Paroxetine and Fluoxetine Effects On Mood and Cognitive Functions in Depressed Nondemented Elderly Patients. Giovanni Battista Cassano, Francomichele Puca, Pier Luigi Scapicchio, and Marco Trabucchi, for the Italian Study Group on Depression in Elderly Patients
[Abstract] [PDF]

403 Characteristics of Opiate Dependent Patients Who Attempt Suicide. Alec Roy
[Abstract] [PDF]

408 Effects of Olanzapine on Prolactin Levels of Female Patients With Schizophrenia Treated With Risperidone. Kwang-Soo Kim, Chi-Un Pae, Jeong-Ho Chae, Won-Myong Bahk, Tae-Youn Jun, Dai-Jin Kim, and Ruth A. Dickson
[Abstract] [PDF]

414 Is Bipolar Disorder Specifically Associated With Panic Disorder in Youths? [CME] Boris Birmaher, Adam Kennah, David Brent, Mary Ehmann, Jeff Bridge, and David Axelson
[Abstract] [PDF]

420 Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia. Daniel S. Umbricht, William C. Wirshing, Donna A. Wirshing, Marjorie McMeniman, Nina R. Schooler, Stephen R. Marder, and John M. Kane
[Abstract] [PDF]

425 A Retrospective Comparison of Weight, Lipid, and Glucose Changes Between Risperidone- and Olanzapine-Treated Inpatients: Metabolic Outcomes After 1 Year. Jonathan M. Meyer
[Abstract] [PDF]

434 Symptomatic and Syndromal Anxiety in Chronic Forms of Major Depression: Effect of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination. Philip T. Ninan, A. John Rush, Paul Crits-Christoph, Susan G. Kornstein, Rachel Manber, Michael E. Thase, Madhukar H. Trivedi, Barbara O. Rothbaum, John Zajecka, Frances E. Borian, and Martin B. Keller
[Abstract] [PDF]

442 Divalproex Sodium Treatment of Women With Borderline Personality Disorder and Bipolar II Disorder: A Double-Blind Placebo-Controlled Pilot Study. Frances R. Frankenburg and Mary C. Zanarini
[Abstract] [PDF]

447 Burning Charcoal: An Indigenous Method of Committing Suicide in Hong Kong. Chi Ming Leung, Wai Sau D. Chung, and Eddie P. M. So
[Abstract] [PDF]

Letters To the Editor

451 Efficacy of 17beta-Estradiol on Depression: Is Estrogen Deficiency Really Necessary? Claudio N. Soares, Hadine Joffe, Lee S. Cohen, and Osvaldo P. Almeida
[PDF]

  • Reply by Antti Ahokas, Jutta Kaukoranta, Kristian Wahlbeck, and Marjatta Aito

452 Dystonia Induced by Mirtazapine. Rui Lu, Adrian D. Hurley, and Mark Gourley
[PDF]

453 Resolution of Hyperglycemia on Risperidone Discontinuation: A Case Report. Ashok Mallya, Pooja Chawla, Susan K. Boyer, and Lori DeRosear
[PDF]

454 Urinary Incontinence With Mirtazapine. Arun Kunwar, Subhdeep Virk, and Prakash S. Masand
[PDF]

455 Efficacy of Continuation Treatment With Hypericum perforatum in Depression. Ronald Brenner, S. Madhusoodanan, and Monika Pawlowska
[PDF]

Book Reviews 456

NOW@Psychiatrist.com 462

Information for authors

see January 2002, pages 83-85 or our Web site at www.psychiatrist.com/author.htm